Allosteric modulators of nicotinic acetylcholine receptors
US9840481B2 · kind B2 · utility
1Cited by
12References
38Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 20, 2017 |
| Grant date | Dec 12, 2017 |
| Priority date | — |
| Expiry date | Mar 20, 2037 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D495/04
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present disclosure relates to compounds of formula I that are useful as modulators of α7 nAChR, compositions comprising such compounds, and the use of such compounds for preventing, treating, or ameliorating disease, particularly disorders of the central nervous system such as cognitive impairments in Alzheimer's disease, Parkinson's disease, and schizophrenia, as well as for L-DOPA induced-dyskinesia and inflammation
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.